Advancements in Antiviral Drug Discovery: A Comprehensive Review

Abstract

The relentless evolution of viruses and the constant threat of emerging infectious diseases underscore the urgent need for innovative antiviral strategies. This review provides an in-depth examination of recent advancements in antiviral drug discovery, encompassing breakthroughs in target identification, novel drug design approaches, and promising therapeutic candidates. The exploration of diverse viral families, including RNA and DNA viruses, highlights the multifaceted challenges faced by researchers in the field. The integration of cutting-edge technologies, such as structural biology, high-throughput screening, and artificial intelligence, has revolutionized the drug discovery process, enabling the identification of potent antiviral agents. Additionally, the review delves into the strategies employed to combat viral resistance, emphasizing the importance of combination therapies and the development of broad-spectrum antivirals. The evolving landscape of antiviral research is also examined in the context of recent global health challenges, including the COVID-19 pandemic, with insights into lessons learned and potential avenues for future research.

How to cite this article:
Tiwari R, Singh M. Advancements in Antiviral
Drug Discovery: A Comprehensive Review. Rec
Trends Pharm Tech Ind 2023; 5(2): 26-33.